1. Home
  2. CAR vs RYTM Comparison

CAR vs RYTM Comparison

Compare CAR & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avis Budget Group Inc.

CAR

Avis Budget Group Inc.

HOLD

Current Price

$162.23

Market Cap

25.2B

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$90.11

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAR
RYTM
Founded
1946
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.2B
6.2B
IPO Year
1998
2017

Fundamental Metrics

Financial Performance
Metric
CAR
RYTM
Price
$162.23
$90.11
Analyst Decision
Sell
Strong Buy
Analyst Count
7
14
Target Price
$136.57
$131.14
AVG Volume (30 Days)
1.4M
685.9K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
50.71
28.34
EPS
N/A
N/A
Revenue
$11,652,000,000.00
N/A
Revenue This Year
$2.10
$55.34
Revenue Next Year
$1.81
$86.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$85.96
$60.15
52 Week High
$847.70
$122.20

Technical Indicators

Market Signals
Indicator
CAR
RYTM
Relative Strength Index (RSI) 43.75 50.52
Support Level $147.86 $87.19
Resistance Level $847.70 $92.17
Average True Range (ATR) 11.74 4.36
MACD 2.19 -0.26
Stochastic Oscillator 59.09 35.06

Price Performance

Historical Comparison
CAR
RYTM

About CAR Avis Budget Group Inc.

Avis Budget Group Inc is a provider of mobility solutions through its three brands Avis, Budget and Zipcar, as well as several other brands, well recognized in their respective markets. Its brands offer a range of options, from car and truck rental to car sharing. The company operates in two reportable business segments: Americas - (i) vehicle rental operations in North America, South America, Central America and the Caribbean, (ii) car sharing operations in certain of these markets, and (iii) licensees in the areas in which do not operate directly. International - consisting of (i) vehicle rental operations in Europe, the Middle East, Africa, Asia and Australasia, (ii) car sharing operations in certain of these markets, and (iii) licensees in the areas in which do not operate directly.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: